Information for Shareholders and Investors

Latest news and press releases

  • 17 nov, 2017

    FDA approval of genetic test for alpha-1 deficiency and EMA approval of fibrin sealant Download (61.1 Kb)

  • 02 nov, 2017

    Grifols increases its revenues by 10% to Euros 3,250 million and grows net profit by 6.3% to reach Euros 432 million Download (401 Kb)

  • 22 sep, 2017

    FDA approves Grifols Prolastin®-C Liquid [alpha-1 proteinase inhibitor, liquid] for the treatment of alpha-1 antitrypsin deficiency Download (159.2 Kb)